Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors
- PMID: 16025518
- DOI: 10.1002/hep.20795
Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors
Abstract
The contribution of intrahepatic conventional T cells to the unique immunologic properties of the liver has not been clearly defined. We isolated bulk and CD4 T cells from mouse liver and compared their functions with each other and with their splenic counterparts. Unlike bulk spleen T cells, bulk liver T cells reacted minimally to allogeneic or antigen-loaded syngeneic dendritic cells. However, after exclusion of natural killer T cells (NKTs) and gammadelta T cells by FACS, liver and spleen CD4 T cells actually proliferated to a similar extent upon allogeneic or antigen-specific stimulation. Liver CD4 T cells were more sensitive to interleukin 2 (IL-2) than were spleen CD4 T cells, but had a similar proliferative potential based on their response to CD3 ligation. In addition, activated liver CD4 T cells produced higher levels of IL-4, IL-5, IL-10, and interferon gamma (IFN-gamma) than did splenic CD4 T cells. Therefore, liver CD4 T cells are intrinsically different from spleen CD4 T cells. In vitro, liver or spleen NKTs and gammadelta T cells suppressed liver and spleen CD4 T-cell proliferation in a dose-dependent fashion. In conclusion, unconventional T cells constrain liver CD4 T-cell function. Our findings have implications for pathological conditions of the liver that involve the response of conventional CD4 T lymphocytes.
Similar articles
-
Regional oral tolerance in transgenic 2C mice.Surgery. 2005 Aug;138(2):141-9. doi: 10.1016/j.surg.2005.05.010. Surgery. 2005. PMID: 16153420
-
[Effect of murine mesenchymal stem cells (mMSC) on the allogeneic immuno-response of syngeneic and allogeneic spleen cells].Zhonghua Xue Ye Xue Za Zhi. 2008 Mar;29(3):196-9. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18788622 Chinese.
-
Activation of thymic T cells by MHC alloantigen requires syngeneic, activated CD4+ T cells and B cells as APC.Int Immunol. 2006 May;18(5):719-28. doi: 10.1093/intimm/dxl009. Epub 2006 Mar 28. Int Immunol. 2006. PMID: 16569677
-
Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.Immunology. 2005 Aug;115(4):451-61. doi: 10.1111/j.1365-2567.2005.02179.x. Immunology. 2005. PMID: 16011514 Free PMC article.
-
NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.Int J Cancer. 2003 Aug 20;106(2):236-43. doi: 10.1002/ijc.11201. Int J Cancer. 2003. PMID: 12800200
Cited by
-
Immunosuppression in liver tumors: opening the portal to effective immunotherapy.Cancer Gene Ther. 2017 Mar;24(3):114-120. doi: 10.1038/cgt.2016.54. Epub 2016 Dec 2. Cancer Gene Ther. 2017. PMID: 27910858 Review.
-
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.Clin Cancer Res. 2015 Jul 15;21(14):3149-59. doi: 10.1158/1078-0432.CCR-14-1421. Epub 2015 Apr 7. Clin Cancer Res. 2015. PMID: 25850950 Free PMC article. Clinical Trial.
-
Challenges in assessing solid tumor responses to immunotherapy.Cancer Gene Ther. 2020 Aug;27(7-8):528-538. doi: 10.1038/s41417-019-0155-1. Epub 2019 Dec 11. Cancer Gene Ther. 2020. PMID: 31822814 Review.
-
Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.J Immunol. 2011 Aug 1;187(3):1150-6. doi: 10.4049/jimmunol.1004077. Epub 2011 Jun 22. J Immunol. 2011. PMID: 21697460 Free PMC article.
-
The prognostic value of liver tumor T cell infiltrates.J Surg Res. 2014 Sep;191(1):189-95. doi: 10.1016/j.jss.2014.06.001. Epub 2014 Jun 7. J Surg Res. 2014. PMID: 25033707 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials